Allscripts (MDRX) Reports In-Line Q3 EPS

Allscripts (NASDAQ: MDRX) reported Q3 EPS of $0.17, in-line with the analyst estimate of $0.17. Revenue for the quarter came in at $445 million versus the consensus estimate of $450.16 million.

GUIDANCE:

Allscripts sees FY2019 EPS of $0.67-$0.70, versus prior of $0.65-$0.70 and the consensus of $0.68.

For earnings history and earnings-related data on Allscripts (MDRX) click here.

You May Also Be Interested In

• Alphabet stock surges 11% to record high on Q1 earnings beat, first-ever dividend
• Edwards Lifesciences (EW) Tops Q1 EPS by 2c; offers guidance
• Universal Logistics Holdings, Inc. (ULH) Tops Q1 EPS by 136c